Tag: HAART 200

US FDA clears Biostable’s HAART 200 bicuspid aortic valve repair annuloplasty device

BioStable Science & Engineering has received US Food and Drug Administration (FDA) market cl...

BioStable Science & Engineering completes direct de novo application to FDA for an aortic annuloplasty device

BioStable Science & Engineering has completed a direct de novo application to the FDA for Cl...